Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.400
-0.050 (-2.04%)
At close: Apr 28, 2026, 4:00 PM EDT
2.406
+0.006 (0.23%)
After-hours: Apr 28, 2026, 6:10 PM EDT
CNTB Employees
Connect Biopharma Holdings had 64 employees as of December 31, 2025. The number of employees increased by 2 or 3.23% compared to the previous year.
Employees
64
Change (1Y)
2
Growth (1Y)
3.23%
Revenue / Employee
$1,000
Profits / Employee
-$866,875
Market Cap
135.65M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 174 |
| Immunic | 92 |
| Agenus | 81 |
| Tenaya Therapeutics | 70 |
| Equillium | 35 |
| TuHURA Biosciences | 22 |
| Edesa Biotech | 17 |
| Spruce Biosciences | 8 |
CNTB News
- 5 days ago - Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis - GlobeNewsWire
- 4 weeks ago - Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Connect Biopharma Holdings Transcript: Study result - Transcripts
- 4 weeks ago - Connect Biopharma Announces $20.2 Million Private Placement Financing - GlobeNewsWire
- 4 weeks ago - Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study - GlobeNewsWire
- 4 weeks ago - Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD - GlobeNewsWire
- 7 weeks ago - Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting - GlobeNewsWire
- 7 weeks ago - Connect Biopharma Holdings Transcript: Leerink Global Healthcare Conference 2026 - Transcripts